Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05976984 · ClinicalTrials.gov registry record

Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
634,939
Enrollment target

NCT05976984: Completed study, sponsored by University of Pennsylvania.

NCT05976984 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 634,939 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05976984 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
634,939 participants
Enrollment target

Study Summary

This project addresses Objective 2 of RFA-CE-21-002: to assess risk and protective factors for illicit stimulant use, use disorder, or overdose that can contribute to the development or adaptation of intervention strategies. The study will 1) develop and validate a model using both person-level and area-level characteristics to identify, among Medicaid enrollees age 15 and older, who is at highest risk of an inpatient hospitalization or emergency department (ED) encounter for overdose from cocaine or other stimulants; 2) develop and validate a model to identify, among those Medicaid enrollees age 15 and older at highest risk of an inpatient hospitalization or ED encounter for stimulant overdose, when they are at highest risk; and 3) among those Medicaid enrollees age 15 and above with a prior inpatient hospitalization or ED encounter for stimulant overdose, to measure the rate of and identify risk and protective factors for a subsequent inpatient hospitalization or ED encounter for overdose from stimulants and/or opioids.

Interventions

  • OTHER Aim 1 (case-cohort study)
  • OTHER Aim 2 (case-crossover study)
  • OTHER Aim 3 (cohort study)

Trial Details

FieldValue
Enrollment Target 634,939 participants
Start Date 2021-09-30
Est. Completion 2025-08-18

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05976984

The ClinicalTrials.gov registry entry for NCT05976984 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 634,939 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Aim 1 (case-cohort study) is the first listed.

NCT05976984 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05976984 about?

NCT05976984 is a clinical study titled "Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk". This project addresses Objective 2 of RFA-CE-21-002: to assess risk and protective factors for illicit stimulant use, use disorder, or overdose that can contribute to the development or adaptation of intervention strategies. The study will 1) develop and validate a model using both person-level and ...

What is the current status of trial NCT05976984?

This trial is currently completed. The enrollment target is 634,939 participants. The study started on 2021-09-30. Estimated completion is 2025-08-18.

What interventions are being tested in trial NCT05976984?

The interventions under investigation include: Aim 1 (case-cohort study) (OTHER), Aim 2 (case-crossover study) (OTHER), Aim 3 (cohort study) (OTHER).

Who is sponsoring clinical trial NCT05976984?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.